Targeted Therapy Drugs Slow the Growth and Spread of Advanced Non-Small Cell Lung Cancer
Two studies showed that treatment with targeted therapy drugs (drugs that target the faulty genes and proteins that contribute to cancer growth) slowed the growth and spread of advanced NSCLC. These studies include:
- Adding the drug erlotinib (Tarceva) to follow-up treatment with the drug bevacizumab (Avastin)
- Adding the drug vandetanib (Zactima) to standard chemotherapy with docetaxel (Taxotere)
For More Information
Cancer.Net Guide to Lung Cancer [1]
ASCO Answers Fact Sheet: Lung Cancer [2]
ASCO Expert Corner: A Decision Aid Tool for Lung Cancer [3]